Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

Autor: John W, Eikelboom, Stuart J, Connolly, Martina, Brueckmann, Christopher B, Granger, Arie P, Kappetein, Michael J, Mack, Jon, Blatchford, Kevin, Devenny, Jeffrey, Friedman, Kelly, Guiver, Ruth, Harper, Yasser, Khder, Maximilian T, Lobmeyer, Hugo, Maas, Jens-Uwe, Voigt, Maarten L, Simoons, Frans, Van de Werf, J, Rogowski

Publikováno v: New England Journal of Medicine, 369(13), 1206-1214. Massachussetts Medical Society
New England journal of medicine, 369(13), 1206-1214. Massachussetts Medical Society

BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. MethodsIn this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4d96d1188472d4b299f2fb1f5268a2
https://pure.eur.nl/en/publications/1274a6e4-557a-4f4a-8a19-5e00d49fbd23